Sgi.Ax
SGI.AX operates in the Diversified Industrial Goods Wholesale industry, providing industrial and commercial services, and generates revenue primarily through the distribution and sale of industrial goods.
Business. Somnigroup International Inc (SGI.O) is a retailer operating within the Broadline & Specialty Retail industry. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
10 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressApril McClain Delaney — Somnigroup International Inc.2026-03-31 · MD · Purchase · $1,001 - $15,000
- CongressApril McClain Delaney — Somnigroup International Inc.2026-03-16 · MD · Purchase · $1,001 - $15,000
- CongressApril McClain Delaney — Somnigroup International Inc.2026-03-13 · MD · Purchase · $1,001 - $15,000
- CongressApril McClain Delaney — Somnigroup International Inc.2026-03-09 · MD · Purchase · $1,001 - $15,000
- CongressApril McClain Delaney — Somnigroup International Inc.2026-02-09 · MD · Sale · $1,001 - $15,000
- CongressApril McClain Delaney — Somnigroup International Inc.2026-01-22 · MD · Sale · $1,001 - $15,000
Pre-earnings brief
Somnigroup International Inc (SGI.O) experienced a significant adjustment in its shareholder registry, specifically regarding investor ID 587. The holding for this investor was initially recorded as 233 shares, valued at approximately $0.017 million, representing a negligible weight of roughly 0.00001% of the company. This figure was subsequently revised upward to 12,285 shares, with a corresponding value of approximately $0.908 million and a weight of about 0.00052%. The correction was detected on June 24, 2026, reversing an earlier entry from June 25, 2026, that had shown the lower share count. Both data points reference the same reporting date of March 31, 2026, indicating that the change reflects a data reconciliation or reporting update rather than a new market transaction during that period. Despite this major severity signal in holder data, there were no other material changes to the company’s fundamental profile. The analysis walked 17 fields and found no shifts in operational or financial metrics, with four schema-expansion fields excluded from the review. Somnigroup International Inc remains a company with limited public analyst coverage, as indicated by zero analyst counts and no index memberships. With 32 top holders identified and no changes in officer count, the primary activity for SGI.O in this period was confined to the correction of this specific institutional holding record.
Signals & dispatch
Composite-score breakdown
Synthesis
Somnigroup International Inc (SGI.O) is a retailer operating within the Broadline & Specialty Retail industry. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
SGI.AX maintains a debt-to-equity ratio of 1.02, indicating a balanced capital structure with liabilities nearly equal to equity. The company's liquidity is assessed as medium, with a current ratio of 1.08, suggesting it has just enough current assets to cover its current liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, SGI.AX reports a return on equity (ROE) of 10.32% and a return on assets (ROA) of 3.38%. These figures suggest the company is generating reasonable returns for shareholders and effectively utilizing its assets, though the ROA is relatively modest compared to industry benchmarks. The operating margin, calculated as operating income of $6.55 million on revenue of $141.73 million, is 4.63%, which is in line with the industry's median operating margin of 4.5%.
SGI.AX's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of its revenue streams. However, the company's exposure to a single market or customer is not explicitly stated, and no major geographic or segment-specific risks are identified in the current financial data.
Looking at the company's growth trajectory, SGI.AX has reported a revenue of $141.73 million in the latest period. While the outlook for the current fiscal year is not explicitly provided, the company's capital expenditure of -$4.89 million indicates a reduction in investment in physical assets, which may suggest a focus on cost optimization or a slowdown in expansion. The free cash flow of $954,780 is positive, indicating the company is generating cash after capital expenditures, which could be used for debt reduction or shareholder returns.
The risk assessment for SGI.AX highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations without additional financing. No significant dilution sources are identified, and the dilution potential is assessed as low, suggesting the company is not expected to issue additional shares in the near term.
Recent events and filings for SGI.AX are not detailed in the available data, so no specific recent developments can be cited. The company's financial statements and disclosures do not indicate any material changes in operations or strategy in the latest reporting period.
Somnigroup International Inc (SGI.O) experienced a significant adjustment in its shareholder registry, specifically regarding investor ID 587. The holding for this investor was initially recorded as 233 shares, valued at approximately $0.017 million, representing a negligible weight of roughly 0.00001% of the company. This figure was subsequently revised upward to 12,285 shares, with a corresponding value of approximately $0.908 million and a weight of about 0.00052%. The correction was detected on June 24, 2026, reversing an earlier entry from June 25, 2026, that had shown the lower share count. Both data points reference the same reporting date of March 31, 2026, indicating that the change reflects a data reconciliation or reporting update rather than a new market transaction during that period. Despite this major severity signal in holder data, there were no other material changes to the company’s fundamental profile. The analysis walked 17 fields and found no shifts in operational or financial metrics, with four schema-expansion fields excluded from the review. Somnigroup International Inc remains a company with limited public analyst coverage, as indicated by zero analyst counts and no index memberships. With 32 top holders identified and no changes in officer count, the primary activity for SGI.O in this period was confined to the correction of this specific institutional holding record.
- SGI.AX has a balanced capital structure with a debt-to-equity ratio of 1.02.
- The company's return on equity is 10.32%, indicating strong profitability for shareholders.
- SGI.AX's liquidity is assessed as medium, with a current ratio of 1.08.
- The company's free cash flow is positive at $954,780, suggesting it can fund operations and reduce debt.
- The risk assessment indicates a low dilution risk and a medium liquidity risk.
- No significant recent events or filings are reported in the latest data.
Bull / Bear case
Generated · model-assistedRevenue surged 51.6% year-over-year to $7.48 billion in fiscal 2026, demonstrating significant top-line expansion momentum.
Analysts project 35.9% upside to a mean price target of $97.25, reflecting strong institutional confidence in future performance.
Cash conversion ratio of 1.53 outperforms the 1.37 cohort median, suggesting robust ability to turn earnings into cash.
Net income declined 11.4% annually over four years, signaling persistent erosion in bottom-line profitability despite revenue growth.
Debt-to-equity ratio of 1.48 places the company in the bottom quartile of peers, indicating elevated financial leverage risk.
Long-term debt increased to $4.69 billion in fiscal 2026, raising concerns about debt servicing capacity and credit risk.
Current ratio of 0.83 indicates potential short-term liquidity constraints, as current assets do not fully cover current liabilities.
In focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- President & CEO Mattress Firm · Stock Options (right to buy) → Common StockDisposed 10 448 @ $15,61exercise · 2026-05-22
- Director · Restricted Stock Units → Common StockDisposed 2 337exercise · 2026-05-14
- Director · Restricted Stock Units → Common StockAcquired 2 657grant · 2026-05-13
- CEO of Tempur Sealy · Performance Restricted Stock Units → Common StockAcquired 22 536grant · 2026-02-26
- Director, CEO & PRESIDENT · Performance Restricted Stock Units → Common StockAcquired 72 120grant · 2026-02-26
- President & CEO Mattress Firm · Performance Restricted Stock Units → Common StockAcquired 13 975grant · 2026-02-26
- EVP Global Business Strategy · Performance Restricted Stock Units → Common StockAcquired 9 015grant · 2026-02-26
- EVP & Chief Financial Officer · Performance Restricted Stock Units → Common StockAcquired 13 975grant · 2026-02-26
- President & CEO Mattress Firm · Restricted Stock Units → Common StockDisposed 4 019exercise · 2026-01-02
- President & CEO Mattress Firm · Performance Restricted Stock Units → Common StockDisposed 14 909exercise · 2026-01-02
- President & CEO Mattress Firm · Performance Restricted Stock Units → Common StockDisposed 6 508exercise · 2026-01-02
- President & CEO Mattress Firm · Restricted Stock Units → Common StockAcquired 14 086grant · 2026-01-02
- CEO of Tempur Sealy · Restricted Stock Units → Common StockDisposed 6 482exercise · 2026-01-02
- CEO of Tempur Sealy · Restricted Stock Units → Common StockDisposed 8 946exercise · 2026-01-02
- CEO of Tempur Sealy · Restricted Stock Units → Common StockDisposed 6 521exercise · 2026-01-02
- CEO of Tempur Sealy · Restricted Stock Units → Common StockDisposed 5 607exercise · 2026-01-02
- CEO of Tempur Sealy · Performance Restricted Stock Units → Common StockDisposed 7 397exercise · 2026-01-02
- CEO of Tempur Sealy · Performance Restricted Stock Units → Common StockDisposed 24 050exercise · 2026-01-02
- CEO of Tempur Sealy · Performance Restricted Stock Units → Common StockDisposed 10 494exercise · 2026-01-02
- CEO of Tempur Sealy · Restricted Stock Units → Common StockAcquired 14 086grant · 2026-01-02
- President & CEO Mattress Firm · Restricted Stock Units → Common StockDisposed 5 547exercise · 2026-01-02
- EVP Global Business Strategy · Restricted Stock Units → Common StockDisposed 3 579exercise · 2026-01-02
- EVP Global Business Strategy · Restricted Stock Units → Common StockDisposed 2 609exercise · 2026-01-02
- EVP Global Business Strategy · Restricted Stock Units → Common StockDisposed 2 243exercise · 2026-01-02
- EVP Global Business Strategy · Performance Restricted Stock Units → Common StockDisposed 2 961exercise · 2026-01-02
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SGI.AX Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,11 %$2 060M
- Institutional Investor · as of 2022-09-300,04 %$0M
- Investment Managers · as of 2026-03-310,03 %$141M
- Investment Managers · as of 2026-03-310,02 %$132M
- Investment Managers · as of 2025-12-310,02 %$1 680M
- Investment Managers · as of 2026-03-310,02 %$359M
- Investment Managers · as of 2026-03-310,02 %$38M
- Investment Managers · as of 2026-03-310,02 %$111M
- Institutional Investor · as of 2026-03-310,02 %$104M
- Investment Managers · as of 2026-03-310,02 %$509M
- Investment Managers · as of 2026-03-310,02 %$131M
- Investment Managers · as of 2024-06-300,02 %$742M
- Investment Managers · as of 2026-03-310,02 %$126M
- Investment Managers · as of 2026-03-310,02 %$105M
- Funds · as of 2026-03-310,02 %$104M
- Institutional Investor · as of 2026-03-310,02 %$33M
- Investment Managers · as of 2026-03-310,01 %$154M
- Investment Managers · as of 2026-03-310,01 %$24M
- Investment Managers · as of 2024-12-310,01 %$25M
- Brokerage Firms · as of 2026-03-310,01 %$22M
- Investment Managers · as of 2026-03-310,01 %$0M
- Institutional Investor · as of 2026-03-310,01 %$11M
- Investment Managers · as of 2026-03-310,00 %$7M
- Institutional Investor · as of 2026-03-310,00 %$15M
- Brokerage Firms · as of 2026-03-310,00 %$18M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$11M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- President & CEO Mattress Firm · Common StockOther 10 448 @ $15,61$163K · 2026-05-22
- President & CEO Mattress Firm · Common StockSold 5 357 @ $66,79$358K · 2026-05-22
- President & CEO Mattress Firm · Common StockSold 1 300 @ $67,48$88K · 2026-05-22
- Director · Common StockOther 2 337 · 2026-05-14
- Director · Common StockOther 702 @ $64,49$45K · 2026-05-14
- Director · Common StockOther 2 657 · 2026-05-13
- Director · Common StockOther 2 657 · 2026-05-13
- Director · Common StockOther 2 657 · 2026-05-13
- Director · Common StockOther 2 657 · 2026-05-13
- Director · Common StockOther 2 657 · 2026-05-13
- Director · Common StockOther 2 657 · 2026-05-13
- Director, CEO & PRESIDENT · Common StockOther 100 748 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 4 019 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 1 833 @ $88,74$163K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 5 547 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 2 530 @ $88,74$225K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 4 043 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 1 844 @ $88,74$164K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 3 476 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 1 586 @ $88,74$141K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 4 588 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 2 093 @ $88,74$186K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 14 909 · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 6 908 @ $88,74$613K · 2026-01-02
- President & CEO Mattress Firm · Common StockOther 6 508 · 2026-01-02
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Revenue (YoY) (2025-12-31 vs 2024-12-31): 51.6%Derived (calculated)
- Net margin (FY 2025-12-31): 5.1%Derived (calculated)
- Gross margin (FY 2025-12-31): 42.6%Derived (calculated)
- Return on assets (FY 2025-12-31): 3.3%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.83xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 71.5%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 47.9%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -15.8%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -14.8%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 57.0%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 22.7%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -0.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 20.0%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 19.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 6.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 94.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 56.8%Derived (calculated)
- Current liabilities (annual): USD 1.57BSEC XBRL filing
- Capex (annual): USD 166.9MSEC XBRL filing
- Net income (annual): USD 384.1MSEC XBRL filing
- Cost of revenue (annual): USD 4.29BSEC XBRL filing
- Pre-tax income (annual): USD 481MSEC XBRL filing
- Long-term debt (annual): USD 4.61BSEC XBRL filing
- Revenue (annual): USD 7.48BSEC XBRL filing